TI
BEAM icon

Trexquant Investment’s Beam Therapeutics BEAM Stock Holding History

Trexquant Investment’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-25,439
Closed -$617K – 1589
2025
Q3 		$617K Sell
25,439
-123,613
-83% -$2.46M 0.01% 1272
2025
Q2 		$2.54M Buy
+149,052
New +$2.6M 0.03% 804
2023
Q4 		– Sell
-14,952
Closed -$360K – 1430
2023
Q3 		$360K Buy
+14,952
New +$401K 0.01% 1150
2023
Q2 		– Sell
-8,164
Closed -$250K – 1443
2023
Q1 		$250K Buy
8,164
+3,025
+59% +$119K 0.01% 1261
2022
Q4 		$201K Sell
5,139
-17,095
-77% -$766K 0.01% 1247
2022
Q3 		$1.06M Sell
22,234
-35,443
-61% -$2.02M 0.04% 511
2022
Q2 		$2.23M Buy
57,677
+36,050
+167% +$1.43M 0.1% 241
2022
Q1 		$1.24M Buy
+21,627
New +$1.42M 0.06% 401
2021
Q4 		– Sell
-13,803
Closed -$1.2M – 1298
2021
Q3 		$1.2M Buy
13,803
+7,259
+111% +$729K 0.1% 281
2021
Q2 		$842K Sell
6,544
-11,334
-63% -$903K 0.07% 347
2021
Q1 		$1.43M Buy
17,878
+9,209
+106% +$876K 0.13% 202
2020
Q4 		$708K Buy
+8,669
New +$426K 0.08% 348

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Trexquant Investment's BEAM Position: Q4 2025 in Review

Trexquant Investment sold out of Beam Therapeutics (BEAM) in Q4 2025, closing a stake of 25,439 shares — an estimated $617K sold.

Trexquant Investment first reported a position in BEAM in Q4 2020 and held it in 12 quarters. The position peaked at $2.54M in Q2 2025. 246 funds tracked by Wall St. Rank hold BEAM as of Q4 2025.

  • Trexquant Investment reported no remaining Beam Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Trexquant Investment sold 25,439 Beam Therapeutics shares in Q4 2025, an estimated $617K.
  • Trexquant Investment first reported a position in Beam Therapeutics in Q4 2020 and held it in 12 quarters.
  • Trexquant Investment's Beam Therapeutics position peaked at $2.54M in Q2 2025.
  • 246 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2025.

Based on Trexquant Investment's 13F filing for Q4 2025, filed 17 Feb 2026.